Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

Ten UCSF graduate students presented their research in accessible, 3-minute talks at the 2025 Grad Slam event. This year’s ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...

Determinants of HIV cell tropism & chemokine receptor usage The V3 loop of HIV-1 gp120 is a primary determinant of cell tropism and chemokine receptor usage, whereas the V1/V2 region is involved ...

If we can identify the cells infected with HIV, it will help bring us closer to figuring out how to eliminate them," said corresponding author Benjamin K. Chen, MD, Ph.D., Professor of Medicine ...

As an HIV researcher for many years, I want to address Dr. Neal Barnard’s dismissive claims in his op-ed in The ...

Researchers at UW are pioneering long-acting injectable HIV therapies that have the potential to simplify and expand ...

This molecule, known as EBC-46, works by temporarily activating the HIV virus in the affected cells as they hide so that the body’s immune system can remove the virus, according to a study published ...

In addition, seven people had been cured of AIDS following a stem-cell transplant from a donor carrying genes that are ...

Novel Point-of-Care Technology Delivers Accurate HIV Results in Minutes Apr. 2 ... Mar. 19, 2025 — New study demonstrates how high-affinity B cells 'bank' their best traits instead of rolling ...

The presence of the central DNA flap in HIV vectors enhances gene transduction in primary neural cells. To determine whether TRIP vectors, which include the central DNA flap, allow improved ...

Gilead’s HIV franchise generated $19.612B in 2024, but faces future funding challenges. Learn why GILD stock is a "Hold" amid ...